Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Change in Inventory (2016 - 2025)

Avanos Medical (AVNS) has disclosed Change in Inventory for 13 consecutive years, with -$2.8 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 93.76% to -$2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$200000.0 through Dec 2025, up 99.49% year-over-year, with the annual reading at -$200000.0 for FY2025, 99.49% up from the prior year.
  • Change in Inventory hit -$2.8 million in Q4 2025 for Avanos Medical, down from $500000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $17.8 million in Q3 2022 to a low of -$44.9 million in Q4 2024.
  • Historically, Change in Inventory has averaged -$1.4 million across 5 years, with a median of -$1.0 million in 2021.
  • Biggest five-year swings in Change in Inventory: soared 2077.78% in 2022 and later tumbled 297.35% in 2024.
  • Year by year, Change in Inventory stood at -$5.8 million in 2021, then grew by 15.52% to -$4.9 million in 2022, then plummeted by 130.61% to -$11.3 million in 2023, then crashed by 297.35% to -$44.9 million in 2024, then skyrocketed by 93.76% to -$2.8 million in 2025.
  • Business Quant data shows Change in Inventory for AVNS at -$2.8 million in Q4 2025, $500000.0 in Q3 2025, and $3.3 million in Q2 2025.